Is it Time for a Therapeutic Algorithm in Resected Pancreatic Ductal Adenocarcinoma?
Sign Up to like & getrecommendations! Published in 2020 at "Pancreas"
DOI: 10.1097/mpa.0000000000001449
Abstract: To the Editor: C onroy et al 1 report that modified FOLFIRINOX (the combination chemotherapy regimen with oxaliplatin, irinotecan, fluorouracil, and leucovorin) achieved a significant median disease-free survival (mDFS) of 21.6 months after a follow-up… read more here.
Keywords: time therapeutic; algorithm resected; ductal adenocarcinoma; pancreatic ductal ... See more keywords